{"name":"Gregg T. Kokame, MD","slug":"gregg-t-kokame-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Intravitreal aflibercept injection 2.0mg","genericName":"Intravitreal aflibercept injection 2.0mg","slug":"intravitreal-aflibercept-injection-2-0mg","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Intravitreal aflibercept injection 2.0mg","genericName":"Intravitreal aflibercept injection 2.0mg","slug":"intravitreal-aflibercept-injection-2-0mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPblFGNTJMTjc4eFF5M3VacFFKX1hXM210aWozOWFocmpmbmtVMGxzMFhYWDZGU2l6NENlSEE2LTdhZ3BxX0E5c0gweTdlaE05TS13T0xxZWxnaXF4Z3dwQ29NSUNmUEtTdTFiOE9UNHV6NUtGYWxYNXR5WGE1aEhYUER4WE9fMmpYLUhWZ2N3?oc=5","date":"2022-02-01","type":"pipeline","source":"American Academy of Ophthalmology","summary":"Polypoidal Choroidal Vasculopathy, Part 2: Treatment - American Academy of Ophthalmology","headline":"Polypoidal Choroidal Vasculopathy, Part 2: Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPZHU5dHNvam1XTXpWSTdLTllGM1pHdUlnb2xYZFJLeS1mM2Fybks0Qmx5Q2tDa29PcUZIY0R1Tzl2dHVidzduWWJMRXRFckxiVUVjRTVBZ2diNV9WZlQ5Nzd0THFiSWlueGlSdktPM0JiNERTYVdjTWc1bVZXTzdNdDZqY0JPb1czZndGUUZR?oc=5","date":"2022-01-01","type":"pipeline","source":"American Academy of Ophthalmology","summary":"Polypoidal Choroidal Vasculopathy, Part 1: Diagnosis - American Academy of Ophthalmology","headline":"Polypoidal Choroidal Vasculopathy, Part 1: Diagnosis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE1aMTRhbWl5Q2p0cmNSUUo4a1ctYzFVb0xVUFhWSmFCR24zZmNWSF9NOUo5Mll1Vkh5YzFkTzRqTDV5ZDBoaVl3S3FTSkd5SHlCNTI5M2p0cFRFUlhEWFc5bHllMTNISlZITmdoZWJkVTBXMzQ?oc=5","date":"2021-08-01","type":"pipeline","source":"American Academy of Ophthalmology","summary":"OCT B-Scans Pin Down Dx of PCV - American Academy of Ophthalmology","headline":"OCT B-Scans Pin Down Dx of PCV","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQMGs5Z0YzY1FldkoyeE5fVWJKX24tc3hQN1lUNjdyeXBsa2cya3p4dy1JTU45VzdnYU9YWnBuOXZ3UUZxWUgxQ2ZEOTlHbV8tQkZxWFNYdnZzRFplWURoY0FaVWV4cXU2cnFPTnZpS1IyWmh6R2N2ODV4blZEam15dDNwVzhGc00?oc=5","date":"2020-05-31","type":"pipeline","source":"American Academy of Ophthalmology","summary":"Endophthalmitis: Which Sampling Method Is Best? - American Academy of Ophthalmology","headline":"Endophthalmitis: Which Sampling Method Is Best?","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}